aluates Reports

$ 0.0

Automative

Global Cardiac Disease Stem Cell Therapy Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-20G17694

BUY CHAPTERS

Global Cardiac Disease Stem Cell Therapy Market Research Report 2024

Code: QYRE-Auto-20G17694

Report

June 2024

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

PHARMICELL

GenCell

BlueRock Therapeutics

Cellino Biotech

Mesoblast Limited

BioCardia

Cedars Sinai

Stem Cells Transplant Institute

CCTRN

Help Therapeutics Co., Ltd.

Beijing Cellapy biotechnology Co., LTD

CardioCell

Heartseed

EmCell

Cardiac Disease Stem Cell Therapy Market

The global Cardiac Disease Stem Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Cardiac Disease Stem Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cardiac Disease Stem Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Cardiac Disease Stem Cell Therapy in Preclinical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Cardiac Disease Stem Cell Therapy include Pharmicell, Gencell, BlueRock Therapeutics, Cellino Biotech, Mesoblast, BioCardia, Cedars-Sinai, Stem Cells Transplant Institute, CCTRN, Help Therapeutics Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cardiac Disease Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Disease Stem Cell Therapy.

The Cardiac Disease Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Disease Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cardiac Disease Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cardiac Disease Stem Cell Therapy Market Report

Report Metric	Details
Report Name	Cardiac Disease Stem Cell Therapy Market
Segment by Type	Autologous Allogeneic
Segment by Application	Preclinical Clinical Phase 1,2
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pharmicell, Gencell, BlueRock Therapeutics, Cellino Biotech, Mesoblast, BioCardia, Cedars-Sinai, Stem Cells Transplant Institute, CCTRN, Help Therapeutics Co., Ltd., Beijing Cellapy biotechnology Co., LTD, CardioCell, Heartseed, EmCell
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiac Disease Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cardiac Disease Stem Cell Therapy Market report?

Ans: The main players in the Cardiac Disease Stem Cell Therapy Market are Pharmicell, Gencell, BlueRock Therapeutics, Cellino Biotech, Mesoblast, BioCardia, Cedars-Sinai, Stem Cells Transplant Institute, CCTRN, Help Therapeutics Co., Ltd., Beijing Cellapy biotechnology Co., LTD, CardioCell, Heartseed, EmCell

What are the Application segmentation covered in the Cardiac Disease Stem Cell Therapy Market report?

Ans: The Applications covered in the Cardiac Disease Stem Cell Therapy Market report are Preclinical, Clinical Phase 1,2

What are the Type segmentation covered in the Cardiac Disease Stem Cell Therapy Market report?

Ans: The Types covered in the Cardiac Disease Stem Cell Therapy Market report are Autologous, Allogeneic

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Autologous

1.2.3 Allogeneic

1.3 Market by Application

1.3.1 Global Cardiac Disease Stem Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Preclinical

1.3.3 Clinical Phase 1,2

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cardiac Disease Stem Cell Therapy Market Perspective (2019-2030)

2.2 Global Cardiac Disease Stem Cell Therapy Growth Trends by Region

2.2.1 Global Cardiac Disease Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cardiac Disease Stem Cell Therapy Historic Market Size by Region (2019-2024)

2.2.3 Cardiac Disease Stem Cell Therapy Forecasted Market Size by Region (2025-2030)

2.3 Cardiac Disease Stem Cell Therapy Market Dynamics

2.3.1 Cardiac Disease Stem Cell Therapy Industry Trends

2.3.2 Cardiac Disease Stem Cell Therapy Market Drivers

2.3.3 Cardiac Disease Stem Cell Therapy Market Challenges

2.3.4 Cardiac Disease Stem Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cardiac Disease Stem Cell Therapy Players by Revenue

3.1.1 Global Top Cardiac Disease Stem Cell Therapy Players by Revenue (2019-2024)

3.1.2 Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Cardiac Disease Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cardiac Disease Stem Cell Therapy Revenue

3.4 Global Cardiac Disease Stem Cell Therapy Market Concentration Ratio

3.4.1 Global Cardiac Disease Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cardiac Disease Stem Cell Therapy Revenue in 2023

3.5 Global Key Players of Cardiac Disease Stem Cell Therapy Head office and Area Served

3.6 Global Key Players of Cardiac Disease Stem Cell Therapy, Product and Application

3.7 Global Key Players of Cardiac Disease Stem Cell Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cardiac Disease Stem Cell Therapy Breakdown Data by Type

4.1 Global Cardiac Disease Stem Cell Therapy Historic Market Size by Type (2019-2024)

4.2 Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Type (2025-2030)

5 Cardiac Disease Stem Cell Therapy Breakdown Data by Application

5.1 Global Cardiac Disease Stem Cell Therapy Historic Market Size by Application (2019-2024)

5.2 Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cardiac Disease Stem Cell Therapy Market Size (2019-2030)

6.2 North America Cardiac Disease Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cardiac Disease Stem Cell Therapy Market Size by Country (2019-2024)

6.4 North America Cardiac Disease Stem Cell Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cardiac Disease Stem Cell Therapy Market Size (2019-2030)

7.2 Europe Cardiac Disease Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cardiac Disease Stem Cell Therapy Market Size by Country (2019-2024)

7.4 Europe Cardiac Disease Stem Cell Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size (2019-2030)

8.2 Asia-Pacific Cardiac Disease Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cardiac Disease Stem Cell Therapy Market Size (2019-2030)

9.2 Latin America Cardiac Disease Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cardiac Disease Stem Cell Therapy Market Size by Country (2019-2024)

9.4 Latin America Cardiac Disease Stem Cell Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size (2019-2030)

10.2 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pharmicell

11.1.1 Pharmicell Company Details

11.1.2 Pharmicell Business Overview

11.1.3 Pharmicell Cardiac Disease Stem Cell Therapy Introduction

11.1.4 Pharmicell Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.1.5 Pharmicell Recent Development

11.2 Gencell

11.2.1 Gencell Company Details

11.2.2 Gencell Business Overview

11.2.3 Gencell Cardiac Disease Stem Cell Therapy Introduction

11.2.4 Gencell Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.2.5 Gencell Recent Development

11.3 BlueRock Therapeutics

11.3.1 BlueRock Therapeutics Company Details

11.3.2 BlueRock Therapeutics Business Overview

11.3.3 BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Introduction

11.3.4 BlueRock Therapeutics Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.3.5 BlueRock Therapeutics Recent Development

11.4 Cellino Biotech

11.4.1 Cellino Biotech Company Details

11.4.2 Cellino Biotech Business Overview

11.4.3 Cellino Biotech Cardiac Disease Stem Cell Therapy Introduction

11.4.4 Cellino Biotech Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.4.5 Cellino Biotech Recent Development

11.5 Mesoblast

11.5.1 Mesoblast Company Details

11.5.2 Mesoblast Business Overview

11.5.3 Mesoblast Cardiac Disease Stem Cell Therapy Introduction

11.5.4 Mesoblast Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.5.5 Mesoblast Recent Development

11.6 BioCardia

11.6.1 BioCardia Company Details

11.6.2 BioCardia Business Overview

11.6.3 BioCardia Cardiac Disease Stem Cell Therapy Introduction

11.6.4 BioCardia Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.6.5 BioCardia Recent Development

11.7 Cedars-Sinai

11.7.1 Cedars-Sinai Company Details

11.7.2 Cedars-Sinai Business Overview

11.7.3 Cedars-Sinai Cardiac Disease Stem Cell Therapy Introduction

11.7.4 Cedars-Sinai Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.7.5 Cedars-Sinai Recent Development

11.8 Stem Cells Transplant Institute

11.8.1 Stem Cells Transplant Institute Company Details

11.8.2 Stem Cells Transplant Institute Business Overview

11.8.3 Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Introduction

11.8.4 Stem Cells Transplant Institute Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.8.5 Stem Cells Transplant Institute Recent Development

11.9 CCTRN

11.9.1 CCTRN Company Details

11.9.2 CCTRN Business Overview

11.9.3 CCTRN Cardiac Disease Stem Cell Therapy Introduction

11.9.4 CCTRN Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.9.5 CCTRN Recent Development

11.10 Help Therapeutics Co., Ltd.

11.10.1 Help Therapeutics Co., Ltd. Company Details

11.10.2 Help Therapeutics Co., Ltd. Business Overview

11.10.3 Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Introduction

11.10.4 Help Therapeutics Co., Ltd. Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.10.5 Help Therapeutics Co., Ltd. Recent Development

11.11 Beijing Cellapy biotechnology Co., LTD

11.11.1 Beijing Cellapy biotechnology Co., LTD Company Details

11.11.2 Beijing Cellapy biotechnology Co., LTD Business Overview

11.11.3 Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Introduction

11.11.4 Beijing Cellapy biotechnology Co., LTD Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.11.5 Beijing Cellapy biotechnology Co., LTD Recent Development

11.12 CardioCell

11.12.1 CardioCell Company Details

11.12.2 CardioCell Business Overview

11.12.3 CardioCell Cardiac Disease Stem Cell Therapy Introduction

11.12.4 CardioCell Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.12.5 CardioCell Recent Development

11.13 Heartseed

11.13.1 Heartseed Company Details

11.13.2 Heartseed Business Overview

11.13.3 Heartseed Cardiac Disease Stem Cell Therapy Introduction

11.13.4 Heartseed Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.13.5 Heartseed Recent Development

11.14 EmCell

11.14.1 EmCell Company Details

11.14.2 EmCell Business Overview

11.14.3 EmCell Cardiac Disease Stem Cell Therapy Introduction

11.14.4 EmCell Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024)

11.14.5 EmCell Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Companies

PHARMICELL

GenCell

BlueRock Therapeutics

Cellino Biotech

Mesoblast Limited

BioCardia

Cedars Sinai

Stem Cells Transplant Institute

CCTRN

Help Therapeutics Co., Ltd.

Beijing Cellapy biotechnology Co., LTD

CardioCell

Heartseed

EmCell

List of Tables

Table 1. Global Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Autologous

Table 3. Key Players of Allogeneic

Table 4. Global Cardiac Disease Stem Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Cardiac Disease Stem Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cardiac Disease Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Cardiac Disease Stem Cell Therapy Market Share by Region (2019-2024)

Table 8. Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Cardiac Disease Stem Cell Therapy Market Share by Region (2025-2030)

Table 10. Cardiac Disease Stem Cell Therapy Market Trends

Table 11. Cardiac Disease Stem Cell Therapy Market Drivers

Table 12. Cardiac Disease Stem Cell Therapy Market Challenges

Table 13. Cardiac Disease Stem Cell Therapy Market Restraints

Table 14. Global Cardiac Disease Stem Cell Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Cardiac Disease Stem Cell Therapy Market Share by Players (2019-2024)

Table 16. Global Top Cardiac Disease Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Disease Stem Cell Therapy as of 2023)

Table 17. Ranking of Global Top Cardiac Disease Stem Cell Therapy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Cardiac Disease Stem Cell Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Cardiac Disease Stem Cell Therapy, Headquarters and Area Served

Table 20. Global Key Players of Cardiac Disease Stem Cell Therapy, Product and Application

Table 21. Global Key Players of Cardiac Disease Stem Cell Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cardiac Disease Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Cardiac Disease Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Application (2019-2024)

Table 29. Global Cardiac Disease Stem Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Cardiac Disease Stem Cell Therapy Revenue Market Share by Application (2025-2030)

Table 31. North America Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Cardiac Disease Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Cardiac Disease Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Cardiac Disease Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Cardiac Disease Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Cardiac Disease Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Cardiac Disease Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. Pharmicell Company Details

Table 47. Pharmicell Business Overview

Table 48. Pharmicell Cardiac Disease Stem Cell Therapy Product

Table 49. Pharmicell Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 50. Pharmicell Recent Development

Table 51. Gencell Company Details

Table 52. Gencell Business Overview

Table 53. Gencell Cardiac Disease Stem Cell Therapy Product

Table 54. Gencell Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 55. Gencell Recent Development

Table 56. BlueRock Therapeutics Company Details

Table 57. BlueRock Therapeutics Business Overview

Table 58. BlueRock Therapeutics Cardiac Disease Stem Cell Therapy Product

Table 59. BlueRock Therapeutics Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 60. BlueRock Therapeutics Recent Development

Table 61. Cellino Biotech Company Details

Table 62. Cellino Biotech Business Overview

Table 63. Cellino Biotech Cardiac Disease Stem Cell Therapy Product

Table 64. Cellino Biotech Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 65. Cellino Biotech Recent Development

Table 66. Mesoblast Company Details

Table 67. Mesoblast Business Overview

Table 68. Mesoblast Cardiac Disease Stem Cell Therapy Product

Table 69. Mesoblast Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 70. Mesoblast Recent Development

Table 71. BioCardia Company Details

Table 72. BioCardia Business Overview

Table 73. BioCardia Cardiac Disease Stem Cell Therapy Product

Table 74. BioCardia Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 75. BioCardia Recent Development

Table 76. Cedars-Sinai Company Details

Table 77. Cedars-Sinai Business Overview

Table 78. Cedars-Sinai Cardiac Disease Stem Cell Therapy Product

Table 79. Cedars-Sinai Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 80. Cedars-Sinai Recent Development

Table 81. Stem Cells Transplant Institute Company Details

Table 82. Stem Cells Transplant Institute Business Overview

Table 83. Stem Cells Transplant Institute Cardiac Disease Stem Cell Therapy Product

Table 84. Stem Cells Transplant Institute Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 85. Stem Cells Transplant Institute Recent Development

Table 86. CCTRN Company Details

Table 87. CCTRN Business Overview

Table 88. CCTRN Cardiac Disease Stem Cell Therapy Product

Table 89. CCTRN Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 90. CCTRN Recent Development

Table 91. Help Therapeutics Co., Ltd. Company Details

Table 92. Help Therapeutics Co., Ltd. Business Overview

Table 93. Help Therapeutics Co., Ltd. Cardiac Disease Stem Cell Therapy Product

Table 94. Help Therapeutics Co., Ltd. Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 95. Help Therapeutics Co., Ltd. Recent Development

Table 96. Beijing Cellapy biotechnology Co., LTD Company Details

Table 97. Beijing Cellapy biotechnology Co., LTD Business Overview

Table 98. Beijing Cellapy biotechnology Co., LTD Cardiac Disease Stem Cell Therapy Product

Table 99. Beijing Cellapy biotechnology Co., LTD Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 100. Beijing Cellapy biotechnology Co., LTD Recent Development

Table 101. CardioCell Company Details

Table 102. CardioCell Business Overview

Table 103. CardioCell Cardiac Disease Stem Cell Therapy Product

Table 104. CardioCell Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 105. CardioCell Recent Development

Table 106. Heartseed Company Details

Table 107. Heartseed Business Overview

Table 108. Heartseed Cardiac Disease Stem Cell Therapy Product

Table 109. Heartseed Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 110. Heartseed Recent Development

Table 111. EmCell Company Details

Table 112. EmCell Business Overview

Table 113. EmCell Cardiac Disease Stem Cell Therapy Product

Table 114. EmCell Revenue in Cardiac Disease Stem Cell Therapy Business (2019-2024) & (US$ Million)

Table 115. EmCell Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Cardiac Disease Stem Cell Therapy Picture

Figure 2. Global Cardiac Disease Stem Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Cardiac Disease Stem Cell Therapy Market Share by Type: 2023 VS 2030

Figure 4. Autologous Features

Figure 5. Allogeneic Features

Figure 6. Global Cardiac Disease Stem Cell Therapy Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Cardiac Disease Stem Cell Therapy Market Share by Application: 2023 VS 2030

Figure 8. Preclinical Case Studies

Figure 9. Clinical Phase 1,2 Case Studies

Figure 10. Cardiac Disease Stem Cell Therapy Report Years Considered

Figure 11. Global Cardiac Disease Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Cardiac Disease Stem Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Cardiac Disease Stem Cell Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global Cardiac Disease Stem Cell Therapy Market Share by Players in 2023

Figure 15. Global Top Cardiac Disease Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Disease Stem Cell Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Cardiac Disease Stem Cell Therapy Revenue in 2023

Figure 17. North America Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Cardiac Disease Stem Cell Therapy Market Share by Country (2019-2030)

Figure 19. United States Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Cardiac Disease Stem Cell Therapy Market Share by Country (2019-2030)

Figure 23. Germany Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Cardiac Disease Stem Cell Therapy Market Share by Region (2019-2030)

Figure 31. China Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Cardiac Disease Stem Cell Therapy Market Share by Country (2019-2030)

Figure 39. Mexico Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Cardiac Disease Stem Cell Therapy Market Share by Country (2019-2030)

Figure 43. Turkey Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. UAE Cardiac Disease Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Pharmicell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 47. Gencell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 48. BlueRock Therapeutics Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 49. Cellino Biotech Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 50. Mesoblast Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 51. BioCardia Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 52. Cedars-Sinai Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 53. Stem Cells Transplant Institute Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 54. CCTRN Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 55. Help Therapeutics Co., Ltd. Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 56. Beijing Cellapy biotechnology Co., LTD Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 57. CardioCell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 58. Heartseed Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 59. EmCell Revenue Growth Rate in Cardiac Disease Stem Cell Therapy Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Liver Stem Cell Therapy Market Research Report 2024

Global Neuronal Regeneration Stem Cell Therapy Market Research Report 2024

Global Cardiology Stem Cells Market Research Report 2024

Global Stem Cell Source Market Research Report 2024

Global Cell Therapy Regenerative Medicine Market Research Report 2025

Global Plant Stem Cell Market Research Report 2025

Global Cell Based Regenerative Therapy Market Research Report 2024

Global Stem Cell Equipment Market Research Report 2024

Global Cell Therapy Manufacturing Market Research Report 2025

Global Stem Cell Therapy Market Insights Forecast to 2030

Global Tissue Regenerative Therapy Market Research Report 2024

Global Stem Cell Cytokines Market Research Report 2024

Global Stem Cell Storage Services Market Research Report 2024

Stem Cell Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Plant Based Stem Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cardiac Medical Devices Market Research Report 2024

Global Stem Cell Lines Manufacturing Market Research Report 2024

Global Cell Regeneration Medicine Market Research Report 2024

Global Cardiac Allografts Market Research Report 2024

RELATED REPORTS

Global Adult Artificial Heart Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32W16534

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33A16598

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Inotropic Drug Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Y16200

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Retrograde Cardioplegia Cannula Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29Z16493

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions